Lp Containing Orphenadrine 2022 - Combined Purchase

CzechTenders notice for Lp Containing Orphenadrine 2022 - Combined Purchase. The reference ID of the tender is 74809932 and it is closing on 19 Dec 2022.

100% Secure Payments

Tender Details

  • Country: Czech Republic
  • Summary: Lp Containing Orphenadrine 2022 - Combined Purchase
  • CZT Ref No: 74809932
  • Deadline: 19 Dec 2022
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: 13613262.00
  • Notice Type: Tender
  • Document Ref. No.: 643235-2022
  • Purchaser's Detail :
  • Purchaser : OLOMOUC UNIVERSITY HOSPITAL
    Address : I. P. Pavlova 185/6
    Town : Olomouc
    NUTS-Code : CZ064 - South Moravian Region
    Postal Code : 77900
    Contact Point : Ing. Pavel Dočkal
    Phone: 420 588443138
    Fax: 420 585413841
    Email :zakazky@fnol.cz
    URL :https://www.fnol.cz/

  • Description :
  • The subject of the public contract is the recurring supply of medicinal products that meet the requirements of SUKL and contain the active substance orphenadrine.
    Doc Title: Muscle relaxants
    Contract Type: Supplies
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
CzechTenders Features

CzechTenders Features

Fresh and verified Tenders from Czech. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Czech in your email inbox.

  Chat with us